| 来源类型 | Working Paper |
| 规范类型 | 报告 |
| DOI | 10.3386/w24210 |
| 来源ID | Working Paper 24210 |
| An Evaluation of the CPI Indexes for Prescription Drugs | |
| Barry Bosworth; John Bieler; Michael Kleinrock; Eric Koepcke; Ernst R. Berndt | |
| 发表日期 | 2018-01-29 |
| 出版年 | 2018 |
| 语种 | 英语 |
| 摘要 | The prescription drug component of the Consumer Price Index (CPI measures recent and past drug price changes, and provides the basis for projecting future price trends and health care expenditures. However, there are concerns about the adequacy of the price data because of recent changes in the structure of the market for prescription drugs. We compare the prescription drug data of the CPI with a large alternative data set from the IQVIA Institute for Human Data Science. We analyze the overall consistency if the data from the two sources, and examine the influence of the large shift from brand to generic drug sales and the increased reliance on third party insurance plans that are excluded from the CPI sampling frame. |
| 主题 | Microeconomics ; Health, Education, and Welfare ; Health ; Industrial Organization ; Market Structure and Firm Performance ; Industry Studies |
| URL | https://www.nber.org/papers/w24210 |
| 来源智库 | National Bureau of Economic Research (United States) |
| 引用统计 | |
| 资源类型 | 智库出版物 |
| 条目标识符 | http://119.78.100.153/handle/2XGU8XDN/581913 |
| 推荐引用方式 GB/T 7714 | Barry Bosworth,John Bieler,Michael Kleinrock,et al. An Evaluation of the CPI Indexes for Prescription Drugs. 2018. |
| 条目包含的文件 | ||||||
| 文件名称/大小 | 资源类型 | 版本类型 | 开放类型 | 使用许可 | ||
| w24210.pdf（320KB） | 智库出版物 | 限制开放 | CC BY-NC-SA | 浏览 | ||
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。
